Davis J - Search Results

1

Comparison of gene expression and flow cytometry for immune profiling in chronic lymphocytic leukaemia.

Sharpe C, Davis J, Mason K, Tam C, Ritchie D, Koldej R. Sharpe C, et al. Among authors: davis j. J Immunol Methods. 2018 Dec;463:97-104. doi: 10.1016/j.jim.2018.09.013. Epub 2018 Sep 26. J Immunol Methods. 2018. PMID: 30267664

2

The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells.

Herst PM, Davis JE, Neeson P, Berridge MV, Ritchie DS. Herst PM, et al. Haematologica. 2009 Jul;94(7):928-34. doi: 10.3324/haematol.2008.003996. Epub 2009 Jun 16. Haematologica. 2009. PMID: 19535345 Free PMC article.

3

B cells in GVHD: friend or foe?

Davis JE, Ritchie DS. Davis JE, et al. Blood. 2010 Mar 25;115(12):2558-9; author reply 2559-60. doi: 10.1182/blood-2009-11-254177. Blood. 2010. PMID: 20339111 Free article. No abstract available.

4

The passive-aggressive relationship between CLL-B cells and T cell immunity.

Davis JE, Ritchie DS. Davis JE, et al. Leuk Res. 2014 Oct;38(10):1160-1. doi: 10.1016/j.leukres.2014.08.005. Epub 2014 Aug 19. Leuk Res. 2014. PMID: 25182688 No abstract available.

5

A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.

Davis JE, Harvey M, Gherardin NA, Koldej R, Huntington N, Neeson P, Trapani JA, Ritchie DS. Davis JE, et al. Biol Blood Marrow Transplant. 2015 Feb;21(2):242-9. doi: 10.1016/j.bbmt.2014.11.003. Epub 2014 Nov 12. Biol Blood Marrow Transplant. 2015. PMID: 25459639 Free article.

6

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.

Neeson PJ, Hsu AK, Chen YR, Halse HM, Loh J, Cordy R, Fielding K, Davis J, Noske J, Davenport AJ, Lindqvist-Gigg CA, Humphreys R, Tai T, Prince HM, Trapani JA, Smyth MJ, Ritchie DS. Neeson PJ, et al. Among authors: davis j. Oncoimmunology. 2015 May 27;4(9):e1038011. doi: 10.1080/2162402X.2015.1038011. eCollection 2015 Sep. Oncoimmunology. 2015. PMID: 26405606 Free PMC article.

7

CIK immunotherapy in refractory hematologic malignancies.

Wong E, Ritchie DS, Davis JE. Wong E, et al. Leuk Res. 2016 Oct;49:60-1. doi: 10.1016/j.leukres.2016.08.005. Epub 2016 Aug 20. Leuk Res. 2016. PMID: 27561991 No abstract available.

8

Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation.

Wong E, Davis JE, Grigg A, Szer J, Ritchie D. Wong E, et al. Among authors: davis je. Bone Marrow Transplant. 2019 Feb;54(2):175-189. doi: 10.1038/s41409-018-0244-z. Epub 2018 Jun 14. Bone Marrow Transplant. 2019. PMID: 29904127 Review.

9

Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes.

Jiao Y, Davis JE, Rautela J, Carrington EM, Ludford-Menting MJ, Goh W, Delconte RB, Souza-Fonseca-Guimaraes F, Koldej R, Gray D, Huang D, Kile BT, Lew AM, Ritchie DS, Huntington ND. Jiao Y, et al. Among authors: davis je. Cell Death Differ. 2019 Aug;26(8):1516-1530. doi: 10.1038/s41418-018-0228-y. Epub 2018 Nov 12. Cell Death Differ. 2019. PMID: 30420758 Free PMC article.

10

Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation.

Wong E, Davis J, Koldej R, Szer J, Grigg A, Ritchie D. Wong E, et al. Among authors: davis j. Leuk Lymphoma. 2020 Jan;61(1):185-188. doi: 10.1080/10428194.2019.1648803. Epub 2019 Aug 7. Leuk Lymphoma. 2020. PMID: 31389281 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,897 results

Search Page

Filters